http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0351625-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1989-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0351625-B1
titleOfInvention Anti-hiv activity of bv-3608
abstract A method is disclosed for preventing the infection of a susceptible living host material when in contact with the human immunodeficiency virus (HIV) or cells infected therewith, which is the known cause of AIDS or pre-AIDS. The method comprises contacting the susceptible living host material with an effective antiviral amount of a BU-3608 compound. The use of a BU-3608 compound for preparing a pharmaceutical composition for preventing the infection of a susceptible living biological substrate with HIV-virus is also disclosed.
priorityDate 1988-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136065670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129319351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466872811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229797032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129569789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18640901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361

Total number of triples: 37.